The Most Advanced 3D Mammograms Available
For Early Detection of Breast Cancer
If you’re a woman over 40, physicians recommend an annual x-ray examination of the breasts, also known as a screening mammogram. Mammograms are helpful in detecting cancer that may be too small for you or your doctor to find in physical examinations.
The St. Luke’s Hospital Women’s Health Center has invested in the most advanced diagnostic technology available. Mammography options include screening and diagnostic digital mammography, 3-D breast tomosynthesis, ultrasound, ultrasound-guided biopsy, needle localizations, stereotactic core biopsy and MRI breast imaging and biopsies.
Taking mammograms personally.
We want you to be informed about mammography and other diagnostic procedures, so that you’ll be comfortable with your choices. That’s why we take every mammogram and every woman’s experience personally. Our personal, confidential approach includes medical services, and individual case management, as needed.
Our dedicated Breast Consultant meets with all patients who receive an irregular mammogram result, offering support and information. She’ll answer questions and act as a liaison between you, referring physicians and other medical professionals.
The Genius 3D Mammography is saving lives.
Did you know that one out of every eight women you know will likely develop breast cancer? If caught early, the 5-year survival rate is almost 100%. That’s why we’ve invested in the Genius™ 3D Mammography™ exam and the Hologic® 3D Mammography™ system. It consists of a 2D and 3D™ image set, where the 2D image can be either an acquired 2D image or a 2D image generated from the 3D™ image set.
- Only the Genius™ 3D Mammography™ exam is FDA approved as superior for women with dense breasts compared to 2D alone.1-7
- Only the Genius™ 3D Mammography™ exam finds 20-65% more invasive breast cancers compared to 2D alone.**1-7
- Studies show that Genius™ 3D Mammography™ exams reduce callbacks by up to 40%.2,3
* Compared to 2D mammography alone. ** Results from Friedewald, SM, et al. “Breast cancer screening using tomosynthesis in combination with digital mammography.” JAMA 311.24 (2014): 2499-2507; a multi-site (13), non-randomized, historical control study of 454,000 screening mammograms investigating the initial impact the introduction of the Hologic Selenia Dimensions on screening outcomes. Individual results may vary. The study found an average 41% increase and that 1.2 (95% CI: 0.8-1.6) additional invasive breast cancers per 1000 screening exams were found in women receiving combined 2D FFDM and 3D(TM) mammograms acquired with the Hologic 3D Mammography(TM) System versus women receiving 2D FFDM mammograms only.
- FDA submissions P080003, P080003/S001, P080003/S004, P080003/S005
- Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 2014 Jun 25;311(24):2499-507.
- Zuckerman SP, Conant EF, Keller BM, et al. Implementation of Synthesized Two-dimensional Mammography in a Population-based Digital Breast Tomosynthesis Screening Program. Radiology. 2016 Dec;281(3):730-736.
- Skaane P, Bandos A, Eben EB, et al. Two-view digital breast tomosynthesis screening with synthetically reconstructed projection images: comparison with digital breast tomosynthesis with full-field digital mammographic images. Radiology. 2014 Jun;271(3):655-63.
- Bernardi D, Macaskill P, Pellegrini M, et. al. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study. Lancet Oncol. 2016 Aug;17(8):1105-13.
- McDonald ES, Oustimov A, Weinstein SP, et al. Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening. JAMA Oncol. 2016 Jun 1;2(6):737-43.
- Rafferty EA, Durand MA, Conant EF, et al. Breast Cancer Screening Using Tomosynthesis and Digital Mammography in Dense and Nondense Breasts. JAMA. 2016 Apr 26;315(16):1784-6.